JUSTIN RYAN: Open Payments
NPI 1174148712 · LAMBERTVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 32 payments from 16 companies in 2025. Trend: 2023 $414 · 2024 $414 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 1 | $143 |
| AstraZeneca Pharmaceuticals LP | 5 | $110 |
| PFIZER INC. | 4 | $80 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $71 |
| Lilly USA, LLC | 3 | $61 |
| Novo Nordisk Inc | 3 | $61 |
| ABBVIE INC. | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $28 |
Products named: Kerecis SurgiClose, AIRSUPRA, Kerendia, NURTEC ODT, Ozempic, AREXVY, VRAYLAR, NEXLETOL.
Industry payments across MI — which companies pay providers there.
